Market Research Report

A quick peek into the report

Global CRISPR Gene Editing Market

Focus on Products, Applications, End Users, Country Data (16 Countries), and Competitive Landscape - Analysis and Forecast, 2020-2030

Some Faq's

Frequently Asked Questions

The CRISPR gene editing market was estimated at $846.2 Million in 2019 and is expected to reach $10.82 Billion by 2030.

Opportunities that are likely to boost the growth of the CRISPR gene editing market includes expanding the gene and cell therapy area and increasing scope of CRISPR gene editing in agriculture.

The applications for which CRISPR gene editing can be used include agricultural, biomedical (gene therapy, drug discovery, and diagnostics), industrial, and other applications [genetically modified foods (gm foods), biofuel, and animal (livestock) breeding]

The end users of CRISPR gene editing include academic institutes and research centers, biotechnology companies, contract research organizations (CROs), and pharmaceutical and biopharmaceutical companies.

Key companies operating in the market include CRISPR Therapeutics, Horizon Discovery Group PLC, Cellecta, Inc., Integrated DNA Technologies, Inc., GenScript Biotech, ToolGen, Inc., System Biosciences LLC, Thermo Fisher Scientific, Inc., Origene Technologies, Inc., GeneCopoeia, Inc., New England Biolabs, Inc., Agilent Technologies, Inc., Applied StemCell, Inc., Abcam, Inc., Rockland Immunochemicals, Inc., Synthego Biosciences, Merck KGaA and Takara Bio
Similar Product

You may also like

Global Cell and Gene Therapy Market
Published Year: 2021

Global Cell and Gene Therapy Market: Focus on Product Type, Therapeutic Class, Pipeline, Regional an

The global cell and gene therapy market was valued at $2,599.7 million in 2020, and it is...